VRXA · ISSUER CIK 2079364
Veraxa Biotech AG
Between Aug 1, 2026 and Oct 29, 2026, 1 Veraxa Biotech AG insiders reported $10K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Hosseinion Warren (Director), with $10K.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$10KInsider buying
$0.00Insider selling
+$10KNet open-market
Sep 29, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 29, 202616:10 | Sep 10, 2026 | VRXA | Director | P · BuyLate 19d | $1.67 | +6,024 | 634,692 | +1% | +$10K | -92.1% | -32.3% |